CHART LIBRARY POWERPOINT TOOL The best way to find out what information a particular CHART library can give you, is to take a look at the summary sheet. To do this, simply click on one of the libraries below. MYOCARDIAL INFARCTION AND ACUTE CORONARY SYNDROME SAFER PRESCRIBING GRASP AF (ATRIAL FIBRILLATION) HEROIN MISUSE MMR VACCINATION PNEUMOCOCCAL VACCINATION LOCAL DELIVERY PLAN (SMOKING & OBESITY) IM&T DES SPARE BUTTON AWAITING FOR ANY NEW LIBRARY CHART & MIQUEST OVERVIEW SUMMARY, CHARTS, DATASHEET EXAMPLE CHART ONLINE
Transcript
CHART LIBRARY POWERPOINT TOOLThe best way to find out what information a particular CHART library can give you, is to take a look at the summary sheet. To
do this, simply click on one of the libraries below.
LOCAL DELIVERY PLAN(SMOKING & OBESITY) IM&T DES SPARE BUTTON AWAITING
FOR ANY NEW LIBRARY
CHART & MIQUESTOVERVIEW
SUMMARY, CHARTS,DATASHEET EXAMPLE
CHARTONLINE
1) Download CHART Software and CHART Query Libraries free from PRIMIS+ Website and install on Practice Computer – (One off process)
2) Create CHART MIQUEST Queries and load them into MIQUEST Interpreter on Clinical System
3) MIQUEST Interpreter interrogates Clinical System Database
4) Obtain CHART MIQUEST Responses from MIQUEST Interpreter on Clinical System
5) Load CHART MIQUEST RESPONSES into CHART Software and see SUMMARY SHEET, DATA SHEET and GRAPHS
HOW CHART & MIQUEST WORK
CLINICALSYSTEM
DATABASE
PRIMIS+ WEBSITE
CHART SOFTWARECHART QUERY LIBRARIES
PRACTICE COMPUTER
CHART SOFTWARECHART QUERY LIBRARIES
PRACTICE COMPUTERSUMMARY SHEET
DATA SHEETGRAPHS
MIQUESTINTERPRETER
BACK TO MENU
Queries on disk/pen
drive/network
Responses on disk/pen drive/network
The NICE MIACS guidance covers such things as dietary advice, exercise advice,referral to cardiac rehabilitation, smoking advice and the use of specific drugs. One area that many PCTs may also have an interest in is the appropriate use of Clopidogrel, an expensive drug used for varying lengths of time after an infarct. The audit will enable practices to see that they are using it in accordance with the guidance. To take a look at a particular area, please click the appropriate button above.
POPULATION ADVICE & PROCEDURES MEDICATION
HEART FAILURE CLOPIDOGREL USAGE MI BY CATEGORY ACS BY CATEGORY
CHOOSE ANOTHERLIBRARY
MI & ACS HOME
MI & ACS
Population
Advice & Procedures
Medication
Heart Failure
Clopidogrel
MI by Category
ACS by Category
TOTAL PRACTICE POPULATION 10620
Population Latest MI in last 12 months
Latest MI over 12 months ago
TOTAL
No of patients who have had an MI 7 130 137
Percent of Practice Population 0.07% 1.22% 1.29%
POPULATION ADVICE & PROCEDURES MEDICATION
HEART FAILURE CLOPIDOGREL USAGE MI BY CATEGORY ACS BY CATEGORY
CHOOSE ANOTHERLIBRARY
MI & ACS HOME
MI & ACS
NO OF PATIENTS PERCENTAGE OF PATIENTS
Advice and Procedures Post MI Latest MI in last 12 months
Latest MI over 12 months ago
TOTAL Latest MI in last 12 months
Latest MI over 12 months ago
TOTAL
No of patients offered exercise advice since last MI 1 37 38 14.3% 28.5% 28%
No of patients whose latest smoking status shows them as smokers 2 11 13 28.6% 8.5% 8%
No of patients given advice to quit smoking since MI 1 53 54 14.3% 40.8% 41%
No of patients referred to cessation service since MI 0 0 0 0.0% 0.0% 0%
No of patients offered dietary advice since last MI 1 33 34 14.3% 25.4% 25%
No of patients offered Cardiac Rehabilitation since last MI 1 1 2 14.3% 0.8% 1%
No of patients recorded as having Bypass Surgery since last MI 1 5 6 14.3% 3.8% 4%
No of patients recorded as having Angioplasty since last MI 1 8 9 14.3% 6.2% 6%
No of patients recorded as having a Stent inserted since last MI 3 16 19 42.9% 12.3% 12%
POPULATION ADVICE & PROCEDURES MEDICATION
HEART FAILURE CLOPIDOGREL USAGE MI BY CATEGORY ACS BY CATEGORY
CHOOSE ANOTHERLIBRARY
MI & ACS HOME
MI & ACS
Medication Post MI ACEI Aspirin BETABLOCKER
STATIN
No of patients with issue for each drug in last three months 98 94 89 106
No of patients with contra-indication code for each drug 1 6 12
Percent on each drug out of all those post MI minus those with contra-indication
72% 72% 71% 79%
Overall Treatment 4 of above drugs
3 of above drugs
2 of above drugs
1 of above drugs
0 of above drugs
TOTAL
No of Post MI patients on or with conta-indication to the combination of drugs
47 53 26 9 2 137
POPULATION ADVICE & PROCEDURES MEDICATION
HEART FAILURE CLOPIDOGREL USAGE MI BY CATEGORY ACS BY CATEGORY
CHOOSE ANOTHERLIBRARY
MI & ACS HOME
MI & ACS
Heart Failure Total Licensed Aldosterone Antagonist issued in last 3 months
Potassium checked in last 3 months
Patients who have had an MI and Left Ventricular Systolic Dysfunction 6 1 2
POPULATION ADVICE & PROCEDURES MEDICATION
HEART FAILURE CLOPIDOGREL USAGE MI BY CATEGORY ACS BY CATEGORY
CHOOSE ANOTHERLIBRARY
MI & ACS HOME
MI & ACS
Diagnostic Categories v Current Clopidogrel Treatment Treatment Advised
Clopidogrel issued in last 3 months
Clopidogrel not issued
1 STEMI in last 1 month Yes 0 0
2 NSTEMI in last 12 months Yes 2 0
3 Stent in last 12 months Yes 3 4
4 Unspecified MI in last 12 months (Does not distinguish STEMI from NSTEMI Ambiguous 1 0
5 STEMI more than 1 month ago No 2 5
6 NSTEMI more than 12 months ago No 0 5
7 Stent more than 12 months ago No 3 25
8 Unspecified MI more than 12 months ago No 5 98
9 ACS Only No 3 10
POPULATION ADVICE & PROCEDURES MEDICATION
HEART FAILURE CLOPIDOGREL USAGE MI BY CATEGORY ACS BY CATEGORY
CHOOSE ANOTHERLIBRARY
MI & ACS HOME
MI & ACS
EXPLANATIONClopidogrel is an expensive drug. It is beneficial for patients in categories 1 to 3. It is not beneficial for patients in categories 5 to 9. Because the type of MI is unspecified, we do not know whether it will be beneficial for patients in category 4.
Therefore the patients represented by red numbers should be on clopidogrel and are not. The patients represented by blue numbers are on clopidogrel even though it is of no benefit to them. The patients represented by green numbers need investigating further before we know whether their clopidogrel status is correct.
Recording of Latest Myocardial Infarction by Category No in last 12 months
No more than 12 months ago
Positional i.e. Antero-Lateral or Posterior 1 8
Q Wave 0 0
Non Q Wave 0 1
Sub-Endocardial 0 2
STEMI 1 3
NSTEMI 3 4
Micro-Infarction 0 0
MI Aborted 0 0
Unspecified 2 112
TOTAL 7 130
POPULATION ADVICE & PROCEDURES MEDICATION
HEART FAILURE CLOPIDOGREL USAGE MI BY CATEGORY ACS BY CATEGORY
CHOOSE ANOTHERLIBRARY
MI & ACS HOME
MI & ACS
EXPLANATIONTo treat an MI correctly, you need to know what type of MI it is. The patients represented by red numbers , particularly hose with an MI in the last 12 months, would need to have a more specific diagnosis put on their medical record.
POPULATION ADVICE & PROCEDURES MEDICATION
HEART FAILURE CLOPIDOGREL USAGE
Latest Acute Coronary Syndrome by Category No in last 12 months
No more than 12 months ago
Acute MI 3 109
STEMI 1 3
NSTEMI 3 4
MI Aborted 0 0
Unstable Angina 1 10
Angina Other 0 0
Preinfarction Syndrome 0 0
Microinfarction 0 0
ACS 1 2
Other 4 20
TOTAL 13 148
MI BY CATEGORY ACS BY CATEGORY
CHOOSE ANOTHERLIBRARY
MI & ACS HOME
MI & ACS
MISUSE BY AGE THERAPY ENGAGEMENT HEPATITIS & HIV
OTHER INFORMATION
CHOOSE ANOTHERLIBRARY
HEROIN MISUSE HOME
HEROIN MISUSE
Please click on the Web Upload icon to send in your data
Heroin Misuse AuditPeople who have ever used heroin
Percent of practice population by relevant age group
Those in treatment in last eight weeks
Percent of heroin misusers seen in last eight weeks
Group/sub-group of heroin misusers TOTAL PERCENT TOTAL PERCENT
Number of heroin misusers 21 0 0 0.0
Number under 18 years 1 0 0 0.0
Number 18-30 years 11 2 0 0.0
Number 30+ years 9 0 0 0.0
People who have ever used heroin
Percent of all heroin misusers
Those in treatment in last eight weeks
Percent of heroin misusers seen in last eight weeks
TOTAL PERCENT TOTAL PERCENT
Evidence of engagement in therapy in past year 0 0.0 0 0.0
Number on prescribed therapy 0 0.0 0 0.0
Evidence of injecting drug misuse ever 0 0.0 0 0.0
Evidence of multiple drug use including alcohol 4 19.0 0 0.0
Evidence of testing for Hepatitis B status ever 1 4.8 0 0.0
No recorded Hepatitis B immunisation 19 90.5 0 0.0
Incomplete Hepatitis B immunisation course 1 4.8 0 0.0
Evidence of completing hepatitis B immunisation course 1 4.8 0 0.0
Evidence of hepatitis C status testing 1 4.8 0 0.0
Evidence of testing for HIV status 0 0.0 0 0.0
Evidence of adverse clinical outcome related to injecting drug misuse 2 9.5 0 0.0
Evidence of unemployment or sickness benefit 7 33.3 0 0.0
Evidence of successful outcome or naltrexone 0 0.0 0 0.0
Number with heroin misuse treatment code without morbidity code 0 0.0 0 0.0
The Heroin Misuse Summary sheet is a collection of tables showing useful information about patients who have misused heroin. To take a look at a table, please click the appropriate button above.
Misuse by Age
Therapy Engagement
Hepatitis & HIV
Other Information
HEROIN MISUSE
People who have ever used heroin
Percent of practice population by relevant age group
Those in treatment in last eight weeks
Percent of heroin misusers seen in last eight weeks
Group/age sub-group of heroin misusers TOTAL PERCENT TOTAL PERCENT
Number of heroin misusers 21 0% 0 0%
Number under 18 years 1 0% 0 0%
Number 18-30 years 11 2% 0 0%
Number 30+ years 9 0% 0 0%
MISUSE BY AGE THERAPY ENGAGEMENT HEPATITIS & HIV
OTHER INFORMATION
CHOOSE ANOTHERLIBRARY
HEROIN MISUSE HOME
HEROIN MISUSE
People who have ever used heroin
Percent of practice population by relevant age group
Those in treatment in last eight weeks
Percent of heroin misusers seen in last eight weeks
Therapy Engagement TOTAL PERCENT TOTAL PERCENT
Evidence of engagement in therapy in past year 0 0.0% 0 0.0%
Number on prescribed therapy 0 0.0% 0 0.0%
Evidence of injecting drug misuse ever 0 0.0% 0 0.0%
Evidence of multiple drug use including alcohol 4 19.0% 0 0.0%
MISUSE BY AGE THERAPY ENGAGEMENT HEPATITIS & HIV
OTHER INFORMATION
CHOOSE ANOTHERLIBRARY
HEROIN MISUSE HOME
HEROIN MISUSE
People who have ever used heroin
Percent of practice population by relevant age group
Those in treatment in last eight weeks
Percent of heroin misusers seen in last eight weeks
Hepatitis & HIV TOTAL PERCENT TOTAL PERCENT
Evidence of testing for Hepatitis B status ever 1 4.8% 0 0.0%
No recorded Hepatitis B immunisation 19 90.5% 0 0.0%
Incomplete Hepatitis B immunisation course 1 4.8% 0 0.0%
Evidence of completing Hepatitis B immunisation course 1 4.8% 0 0.0%
Evidence of Hepatitis C status testing 1 4.8% 0 0.0%
Evidence of testing for HIV status 0 0.0% 0 0.0%
MISUSE BY AGE THERAPY ENGAGEMENT HEPATITIS & HIV
OTHER INFORMATION
CHOOSE ANOTHERLIBRARY
HEROIN MISUSE HOME
HEROIN MISUSE
People who have ever used heroin
Percent of practice population by relevant age group
Those in treatment in last eight weeks
Percent of heroin misusers seen in last eight weeks
Other Information TOTAL PERCENT TOTAL PERCENT
Evidence of adverse clinical outcome related to injecting drug misuse
2 9.5% 0 0.0%
Evidence of unemployment or sickness benefit 7 33.3% 0 0.0%
Evidence of successful outcome or naltrexone 0 0.0% 0 0.0%
Number of heroin misuse treatment code without morbidity code 0 0.0% 0 0.0%
MISUSE BY AGE THERAPY ENGAGEMENT HEPATITIS & HIV
OTHER INFORMATION
CHOOSE ANOTHERLIBRARY
HEROIN MISUSE HOME
LDP – LOCAL DELIVERY PLAN
The aim of the Local Delivery Plan analysis package for Smoking and Obesity is to enable practices to extract, process and send the required data specified by the Department of Health to your PCT.
The data is broken down into tables that show the practice population, and the age/sex of all patients with a BMI and Smoking Status
SMOKING OBESITYCHOOSE ANOTHERLIBRARY
LDP HOME
Smoking
Obesity
LDP – LOCAL DELIVERY PLAN
Age-Sex Breakdown of Patients aged 16 and over
16-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+ Grand Total
Age-Sex Breakdown of Patients aged 16 and with BMI Record in Last 15 Months of 30 or More or Obesity Recorded
16-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+ Grand Total
Females 1 9 3 7 11 16 13 21 19 20 16 14 19 169
Males 0 2 4 4 4 21 10 15 25 27 19 16 19 166
Totals 1 11 7 11 15 37 23 36 44 47 35 30 38 335
SAFER PRESCRIBINGPOSSIBLE INAPPROPRIATE
PRESCRIBINGPOSSIBLE INADEQUATE MONITORING – PART 1
POSSIBLE INADEQUATE MONITORING – PART 2
POSSIBLE INAPPROPRIATEDRUG FOR AGE
POSSIBLE OVERLOOKEDSAFETY INFORMATION
POSSIBLE OVERLOOKEDLABORATORY TESTS
CHOOSE ANOTHERLIBRARY
SAFER PRESCRIBING HOME
The Safer Prescribing Library allows practices to examine their current prescribing to identify issues or even systems which might need attention. To take a look at some of the summary sheets available, please click the appropriate button above.
SAFER PRESCRIBING
POTENTIALLY INAPPROPRIATE PRESCRIBINGCondition and Prescribed Drug Total
Patients with history of Peptic Ulcer prescribed NSAID in Last 4 Months 3
Patients with history of Peptic Ulcer prescribed NSAID in Last 4 Months Without Gastroprotection 1
Active Asthma patient prescribed Beta Blocker in Last 12 Months 2
Women with Venous Thrombosis prescribed Oestrogen in Last 6 Months 1
Patient with history of Gout prescribed Diuretic in Last 4 Months 0
Patients with Aortic Stenosis prescribed Nitrate in Last 12 Months 2
POSSIBLE INAPPROPRIATE PRESCRIBING
POSSIBLE INADEQUATE MONITORING – PART 1
POSSIBLE INADEQUATE MONITORING – PART 2
POSSIBLE INAPPROPRIATEDRUG FOR AGE
POSSIBLE OVERLOOKEDSAFETY INFORMATION
POSSIBLE OVERLOOKEDLABORATORY TESTS
CHOOSE ANOTHERLIBRARY
SAFER PRESCRIBING HOME
SAFER PRESCRIBING
POTENTIALLY INADEQUATE MONITORING – PART 1
Methotrexate Total FBC LFT U&E
Patients prescribed Methotrexate in Last 6 Months 12
Patients with test in Last 3 Months 5 4 6
Patients without test in Last 3 Months 7 8 6
Warfarin Total INR L2M No INR L2M
19 5 14
Lithium Total Serum Lith L3M No Serum Lith L3M
1 0 1
Amiodarone Total TFT LFT
Patients prescribed Amiodarone in Last 6 Months 0
Patients with test in Last 12 Months 0 0
Patients without test in Last 12 Months 0 0
POSSIBLE INAPPROPRIATE PRESCRIBING
POSSIBLE INADEQUATE MONITORING – PART 1
POSSIBLE INADEQUATE MONITORING – PART 2
POSSIBLE INAPPROPRIATEDRUG FOR AGE
POSSIBLE OVERLOOKEDSAFETY INFORMATION
POSSIBLE OVERLOOKEDLABORATORY TESTS
CHOOSE ANOTHERLIBRARY
SAFER PRESCRIBING HOME
SAFER PRESCRIBING
POTENTIALLY INADEQUATE MONITORING – PART 2
ACEI & ACEII Total U&E L12M No U&E L12M
Patients prescribed ACEI/ACEII in Last 6 Months 0 0 0
Azathioprine Total FBC L3M No FBC L3M
Patients prescribed Azathrioprine in Last 6 Months 0 0 0
Penicillamine Total FBC L1M No FBC L1M
Patients prescribed Pencillamine in Last 6 Months 0 0 0
Patients (>=75 yrs old) prescribed NSAID in Last 3 Months with Gastroprotection in Last 12 Months 6
Patients (>=75 yrs old) prescribed NSAID in Last 3 Months without Gastroprotection in Last 12 Months
13
POSSIBLE INAPPROPRIATE PRESCRIBING
POSSIBLE INADEQUATE MONITORING – PART 1
POSSIBLE INADEQUATE MONITORING – PART 2
POSSIBLE INAPPROPRIATEDRUG FOR AGE
POSSIBLE OVERLOOKEDSAFETY INFORMATION
POSSIBLE OVERLOOKEDLABORATORY TESTS
CHOOSE ANOTHERLIBRARY
SAFER PRESCRIBING HOME
SAFER PRESCRIBING
POTENTIALLY OVERLOOKED SAFETY INFORMATIONDrugs Prescribed Total
Prescription of Verapamil in Last 12 Months within 56 days of prescription of Beta Blocker 3
Prescription of NSAID in Last 12 Months within 56 days of prescription of Warfarin 1
Prescription of cipro/norfloxacin in Last 12 Months within 56 days of prescription of Theophylline 2
Prescription of Phosphodiesterase in Last 12 Months within 56 days of prescription of Nitrate 1
Prescription of Quinine in Last 12 Months within 56 days of prescription of Cardiac Glycoside 2
Prescription of Penicillin after allergy read coded 0
Prescription of Penicillin after adverse reacion read coded 2
POSSIBLE INAPPROPRIATE PRESCRIBING
POSSIBLE INADEQUATE MONITORING – PART 1
POSSIBLE INADEQUATE MONITORING – PART 2
POSSIBLE INAPPROPRIATEDRUG FOR AGE
POSSIBLE OVERLOOKEDSAFETY INFORMATION
POSSIBLE OVERLOOKEDLABORATORY TESTS
CHOOSE ANOTHERLIBRARY
SAFER PRESCRIBING HOME
SAFER PRESCRIBING
POTENTIALLY OVERLOOKED LABORATORY TEST RESULTSHypothyroid Recording Total
TSH level over 10 ever with no diagnosis of Hypothyroidism 5
Patients with Duplicated GFR Test Entries from Lablinks 0
Possible Retest Required
One eGFR <30 ml/min in Last 12 Months 0
One eGFR 30 – 59 ml/min in Last 12 Months 28
Possible CKD Diagnosis Required
2 GFR Tests in Last 12 Months Latest <30ml/min and no CKD4/5 diagnosis code 0
2 GFR Tests in Last 12 Months Latest 30 - 59/min and no CKD3 diagnosis code 9
Diabetes Recording
Glucose over 11 ever with no diagnosis of Diabetes 4
POSSIBLE INAPPROPRIATE PRESCRIBING
POSSIBLE INADEQUATE MONITORING – PART 1
POSSIBLE INADEQUATE MONITORING – PART 2
POSSIBLE INAPPROPRIATEDRUG FOR AGE
POSSIBLE OVERLOOKEDSAFETY INFORMATION
POSSIBLE OVERLOOKEDLABORATORY TESTS
CHOOSE ANOTHERLIBRARY
SAFER PRESCRIBING HOME
GRASP AF – (ATRIAL FIBRILLATION)ATRIAL FIBRILLATION
& CHADS SCORE WARFARINCHOOSE ANOTHERLIBRARY
ATRIAL FIBRILLATION HOME
What does GRASP-AF do?Provides a set of MIQUEST queries to identify, for your practice, patients with a diagnosis of AF who are not on warfarin
The GRASP - AF tool will calculate their stroke risk using the validated CHADS2 scoring system.
The tool will highlight patients with a CHADS2 score of 2 or more not receiving warfarin who would benefit from review to assess the issue of anti-coagulation.
The tool does not assess contraindications to warfarin, the decision whether or not to start warfarin remains a clinical one.
Click on the buttons above to see the information that is available on the CHART summary sheets.
AF & CHADS Score
Warfarin
GRASP AF – (ATRIAL FIBRILLATION)
NO PERCENT
Total No of Patients currently registered with Practice 5342
Total No of Patients with Atrial Fibrillation / Flutter 84 1.57%
% of practice population aged 65+ with Atrial Fibrillation / Flutter 6.12%
Risk Profile for Thromboembolism NO PERCENT
CHADS2 Score = 0 8 9.52%
CHADS2 Score = 1 23 27.38%
CHADS2 Score > 1 53 63.10%
TOTAL 84 100.00%
ATRIAL FIBRILLATION& CHADS SCORE WARFARINCHOOSE
ANOTHERLIBRARY
ATRIAL FIBRILLATION HOME
GRASP AF – (ATRIAL FIBRILLATION)
Warfarin use in high risk patients (CHADS2 > 1) NO PERCENT
Patients on warfarin 9 16.98%
Patients not on warfarin 44 83.02%
% of practice population aged 65+ with Atrial Fibrillation / Flutter 6.12%
Patients on warfarin and anti-platelet agents in CHADS2 groups
None Anti-platelet Warfarin Both
CHADS2 Score = 0 8 0 0 0
CHADS2 Score = 1 17 2 4 0
CHADS2 Score > 1 39 5 4 5
ATRIAL FIBRILLATION& CHADS SCORE WARFARINCHOOSE
ANOTHERLIBRARY
ATRIAL FIBRILLATION HOME
MMR CATCHUP CAMPAIGNMMR SUMMARY
SHEETCHOOSE
ANOTHERLIBRARY
MMR HOME
The MMR CHART library has been designed to enable practices to identify patients that fall into the first three priority age groups specified in the Chief Medical Officer MMR Catch-Up Programme letter dated 6th August 2008. The library identifies patients under the age of nineteen that have had zero, one, or two MMR vaccinations to enable practices to review patient details for recall.
MMR CATCHUP CAMPAIGN
SUMMARY SHEET PLEASE ENSURE YOU READ THE ADVICE FILE BEFORE CONTINUINGAge Group Total no
registeredZero doses of MMR given
Percentage One dose of MMR given
Percentage Two doses of MMR given
Percentage
Age 2 years 43 6 13.95% 37 86.05% 0 0.00%
Age 3 years 38 1 2.63% 16 42.11% 21 55.26%
Age 4 years 40 4 10.00% 6 15.00% 30 75.00%
Age 5 years 35 0 0.00% 2 5.71% 33 94.29%
Age 6 years 45 5 11.11% 7 15.56% 33 73.33%
Age 7 years 16 0 0.00% 4 25.00% 12 75.00%
Age 8 years 22 1 4.55% 8 36.36% 13 59.09%
Age 9 years 20 1 5.00% 6 30.00% 13 65.00%
Age 10 years 25 1 4.00% 4 16.00% 20 80.00%
Age 11 years 19 3 15.79% 7 36.84% 9 47.37%
↓ ↓ ↓ ↓ ↓ ↓ ↓ ↓
Age 17 years 25 3 12.00% 6 24.00% 16 64.00%
Age 18 years 28 1 3.57% 11 39.29% 16 57.14%
TOTAL: Age 2 – 18 years 466 38 8.15% 143 30.69% 285 61.16%
MMR SUMMARYSHEET
CHOOSE ANOTHERLIBRARY
MMR HOME
IM&T DESDRUGS TO DISEASE
AUDITSALLERGY
AUDITCHOLECYSTECTOMY
AUDITHYSTERECTOMY
AUDITWRONG SEX
AUDITREFERRALS, LOCATION,
SUMMARY AUDITTOP LEVEL CODES
AUDIT
CHOOSE ANOTHERLIBRARY
IM&T DES HOME
The PRIMIS+ IM&T DES CHART Library was designed to help practices to achieve accredited data quality standards so that their information is fit for sharing in the NHS Care Records Service. This is a key objective of the IM&T DES.
To see the summary sheets from some of the IM&T DES Queries, please click on the buttons above.
IM&T DES – DRUGS TO DIAGNOSIS AUDITSDRUGS TO DIAGNOSIS
AUDIT 1DRUGS TO DIAGNOSIS
AUDIT 2DRUGS TO DIAGNOSIS
AUDIT 3DRUGS TO DIAGNOSIS
AUDIT 4DRUGS TO DIAGNOSIS
AUDIT 5DRUGS TO DIAGNOSIS
AUDIT 6
IMT DESHOME
DRUGS TO DIAGNOSISHOME
THE DIAGNOSES COVERED IN EACH OF THE DRUGS TO DIAGNOSES AUDITS ARE:
DRUGS TO DIAGNOSIS AUDIT 1
Breast CancerGlaucomaPernicious AnaemiaHypothyroid
DRUGS TO DIAGNOSIS AUDIT 2
Asthma / UrtcariaAF or Heart FailureDysrhthmiaGout (1)Raised Intra Ocular Pressure
Patients on Tamoxifen v Breast Cancer Diagnosis 17 16 1 94.1%
Patients on Latanoprost / Timolol / Dorzolamide v Glaucoma Diagnosis
55 53 2 96.4%
Patients on Hydroxocobalamin v Pernicious Anaemia Diagnosis
28 26 2 92.9%
Patients on Levothyroxine v Hypothyroid Diagnosis 196 190 6 96.9%
DRUGS TO DIAGNOSISAUDIT 1
DRUGS TO DIAGNOSISAUDIT 2
DRUGS TO DIAGNOSISAUDIT 3
DRUGS TO DIAGNOSISAUDIT 4
DRUGS TO DIAGNOSISAUDIT 5
DRUGS TO DIAGNOSISAUDIT 6
IMT DESHOME
DRUGS TO DIAGNOSISHOME
IM&T DES – DRUGS TO DIAGNOSIS AUDITS
DRUGS TO DISEASE AUDIT 2
Total No. of Patients on the drug(s)
No. with appropriate
diagnosis
No. without diagnosis
Percentage with
diagnosis
Patients on Montelukast v Asthma / Urtcaria Diagnosis
30 28 2 93.3%
Patients on Digoxin v AF or Heart Failure Diagnosis 79 77 2 97.5%
Patients on Amiodarone / Disopramide v Dysrhthmia Diagnosis
11 11 0 100.0%
Patients on Allopurinol v Gout Diagnosis 53 51 2 96.2%
Patients on Cartelol, Pilocarpine, Brinzolamide, Brimonidine v Raised Intra Ocular Pressure Diagnosis
23 21 2 91.3%
DRUGS TO DIAGNOSISAUDIT 1
DRUGS TO DIAGNOSISAUDIT 2
DRUGS TO DIAGNOSISAUDIT 3
DRUGS TO DIAGNOSISAUDIT 4
DRUGS TO DIAGNOSISAUDIT 5
DRUGS TO DIAGNOSISAUDIT 6
IMT DESHOME
DRUGS TO DIAGNOSISHOME
IM&T DES – DRUGS TO DIAGNOSIS AUDITS
DRUGS TO DISEASE AUDIT 3
Total No. of Patients on the drug(s)
No. with appropriate
diagnosis
No. without diagnosis
Percentage with
diagnosis
Patients on Insulins and Other Antidiabetics except Metformin v Diabetes Diagnosis
170 170 0 100.0%
Patients on Lamotrignine v Epilespy Diagnosis 13 12 1 92.3%
Patients on Colchicine v Gout Diagnosis 13 10 3 76.9%
Patients on Bisphosphonates v Osteoporosis Risk Diagnosis
67 59 8 88.1%
DRUGS TO DIAGNOSISAUDIT 1
DRUGS TO DIAGNOSISAUDIT 2
DRUGS TO DIAGNOSISAUDIT 3
DRUGS TO DIAGNOSISAUDIT 4
DRUGS TO DIAGNOSISAUDIT 5
DRUGS TO DIAGNOSISAUDIT 6
IMT DESHOME
DRUGS TO DIAGNOSISHOME
IM&T DES – DRUGS TO DIAGNOSIS AUDITS
DRUGS TO DISEASE AUDIT 4
Total No. of Patients on the drug(s)
No. with appropriate
diagnosis
No. without diagnosis
Percentage with
diagnosis
Patients on Paroxetine v Depression Diagnosis 70 64 6 91.4%
Patients on Predfoam Budesonide Rectal v Inflammatory Bowel Disease Diagnosis
3 3 0 100.0%
Patients on Levetiracetam v Epilepsy Diagnosis 3 3 0 100.0%
Patients on Clozapine / Risperidone / Olanzapine v Psychosis Diagnosis
42 42 0 100.0%
Patients on Inhaled (Lung) Steroids v Respiratory Disease Diagnosis
565 544 21 96.3%
DRUGS TO DIAGNOSISAUDIT 1
DRUGS TO DIAGNOSISAUDIT 2
DRUGS TO DIAGNOSISAUDIT 3
DRUGS TO DIAGNOSISAUDIT 4
DRUGS TO DIAGNOSISAUDIT 5
DRUGS TO DIAGNOSISAUDIT 6
IMT DESHOME
DRUGS TO DIAGNOSISHOME
IM&T DES – DRUGS TO DIAGNOSIS AUDITS
DRUGS TO DISEASE AUDIT 5
Total No. of Patients on the drug(s)
No. with appropriate
diagnosis
No. without diagnosis
Percentage with
diagnosis
Patients on Roaccutane/Tretinoin v Acne Diagnosis 2 2 0 100.0%
Patients on Fluoxetine v Depression Diagnosis 123 118 5 95.9%
Patients on Mesalazine v Inflammatory Bowel Disease Diagnosis
17 17 0 100.0%
Patients on Depot Antipsychotics and Psychosis Diagnosis
9 8 1 88.9%
Patients on Gold, Penicillamine or Leflunomide and RA / Inflam Arthritis Diagnosis
5 5 0 100.0%
DRUGS TO DIAGNOSISAUDIT 1
DRUGS TO DIAGNOSISAUDIT 2
DRUGS TO DIAGNOSISAUDIT 3
DRUGS TO DIAGNOSISAUDIT 4
DRUGS TO DIAGNOSISAUDIT 5
DRUGS TO DIAGNOSISAUDIT 6
IMT DESHOME
DRUGS TO DIAGNOSISHOME
IM&T DES – DRUGS TO DIAGNOSIS AUDITS
DRUGS TO DISEASE AUDIT 6
Total No. of Patients on the drug(s)
No. with appropriate
diagnosis
No. without diagnosis
Percentage with
diagnosis
Patients on Pizotifen v Migraine Diagnosis 22 18 4 81.8%
Patients on Calcipotriol v Psoriasis Diagnosis 44 42 2 95.5%
Patients on Bicalutamide / Buserelin / Goserelin / Flutamide v Prostate Cancer Diagnosis
10 10 0 100.0%
Patients on Tiotropium v COPD Diagnosis 23 20 3 87.0%
DRUGS TO DIAGNOSISAUDIT 1
DRUGS TO DIAGNOSISAUDIT 2
DRUGS TO DIAGNOSISAUDIT 3
DRUGS TO DIAGNOSISAUDIT 4
DRUGS TO DIAGNOSISAUDIT 5
DRUGS TO DIAGNOSISAUDIT 6
IMT DESHOME
DRUGS TO DIAGNOSISHOME
IM&T DES ALLERGY AUDITNON DRUG
ALLERGY AUDITDRUG
ALLERGY AUDITIMT DESHOME
ALLERGY AUDIT HOME
NON Drug Allergy
Drug Allergy
IM&T DES ALLERGY AUDIT
NON DRUG ALLERGY FROM MIQUEST TOTAL NUMBER RATE PER 1000 PATIENTS
Total No. of Patients who have a Non Drug Allergy Code 139 18.7
Total No. of Patients with Food Allergy Codes 11 1.5
Total No. of Patients with Allergies to Venom (Bee & Wasp Stings) 10 1.3
Total No. of Patients with any other Non Drug Allergy entry 118 15.9
Total No. Non Drug Allergy entries 206 27.7
Total No. Food Allergy entries 19 2.6
Total No. Allergies to Venom (Bee & Wasp Stings) 15 2.0
Total No. Any other Non Drug Allergy entries 172 23.1
NON DRUGALLERGY AUDIT
DRUGALLERGY AUDITIMT DES
HOME
ALLERGY AUDIT HOME
IM&T DES ALLERGY AUDIT
DRUG ALLERGY FROM SYSTEM SUPPLIER REPORTS TOTAL NUMBER RATE PER 1000 PATIENTS
Total No. of Patients who have Drug Allergies 22 2.2
Total No. of Drug Allergies 31 3.1
Total No. of Patients with Penicillin Allergy 16 1.6
Total No. of Patients with Antibiotic Allergy 16 1.6
Total No. of Patients with Gastro-Intestinal Drug Allergies 2 0.2
Total No. of Patients with Cardiovascular Drug Allergies 5 0.5
Total No. of Patients with CNS Drug Allergy 4 0.4
Total No. of Patients with Musculoskeletal Drug Allergy 5 0.5
NON DRUGALLERGY AUDIT
DRUGALLERGY AUDITIMT DES
HOME
ALLERGY AUDIT HOME
IM&T DES CHOLECYSTECTOMY AUDIT
CHOLECYSTECTOMY AUDIT TOTAL NUMBER OFPATIENTS WITH RECORD
PERCENTAGE
Total No. of Patients who have had a Cholecystectomy 151
Total No. with 1 entry 106 70.2%
Total No. with 2 entries 20 13.2%
Total No. with 3 entries 13 8.6%
Total No. with more than 3 entries 12 7.9%
TIME DIFFERENCE WHERE MULTIPLE ENTRIES
Less than a month between first and last entry 19 12.6%
One month to one year between first and last entry 20 13.2%
Over one year between first and last entry 6 4.0%
Total No. with a high level code added 6 4.0%
Total No. Recorded as having an Endoscopic Cholecysectomy 62 41.1%
DRUGS TO DISEASEAUDITS
ALLERGYAUDIT
CHOLECYSTECTOMYAUDIT
HYSTERECTOMYAUDIT
WRONG SEXAUDIT
REFERRALS, LOCATION,SUMMARY AUDIT
TOP LEVEL CODESAUDIT
CHOOSE ANOTHERLIBRARY
IM&T DES HOME
IM&T DES HYSTERECTOMY AUDIT
HYSTERECTOMY AUDIT TOTAL NUMBER OFPATIENTS WITH RECORD
PERCENTAGE
Total No. of Patients who have had a Hysterectomy 330
Total No. with 1 entry 150 45.5%
Total No. with 2 entries 92 27.9%
Total No. with 3 entries 31 9.4%
Total No. with more than 3 entries 57 17.3%
TIME DIFFERENCE WHERE MULTIPLE ENTRIES
Less than a month between first and last entry 37 11.2%
One month to one year between first and last entry 69 20.9%
Over one year between first and last entry 74 22.4%
Total No. with a high level code added 4 1.2%
Total No. Recorded as having a Cervical Smear after Hysterectomy 19 5.8%
DRUGS TO DISEASEAUDITS
ALLERGYAUDIT
CHOLECYSTECTOMYAUDIT
HYSTERECTOMYAUDIT
WRONG SEXAUDIT
REFERRALS, LOCATION,SUMMARY AUDIT
TOP LEVEL CODESAUDIT
CHOOSE ANOTHERLIBRARY
IM&T DES HOME
IM&T DES WRONG SEX AUDITFEMALE CODES
IN MALE RECORDSMALE CODES
IN FEMALE RECORDSIMT DESHOME
WRONG SEX AUDIT HOME
Female Codes In Male Records
Male Codes In Female Records
IM&T DES WRONG SEX AUDIT
FEMALE CODES IN MALE RECORDS TOTAL NO. OFPATIENTS WITH RECORD
RATE PER1000 PATIENTS
Total No. of Males with Female Codes 67 9.0
NO. OF PATIENTS WITH RECORD EVER
NO. OF PATIENTS WITH RECORD IN LAST 6 MONTHS
Males with any Female Codes 67 3
Males with Female Contraception Codes 0 0
Males with Pregnancy Process Codes (62%) 50 1
Males with Obstetric Codes (L%) 6 1
Males with Female Operation Codes 3 0
Males with Female Referral Codes 4 1
Males with Cervical Smear Codes 5 0
FEMALE CODESIN MALE RECORDS
MALE CODESIN FEMALE RECORDSIMT DES
HOME
WRONG SEX AUDIT HOME
IM&T DES WRONG SEX AUDIT
MALE CODES IN FEMALE RECORDS TOTAL NO. OFPATIENTS WITH RECORD
RATE PER1000 PATIENTS
Total No. of Females with Male Codes 5 0.7
NO. OF PATIENTS WITH RECORD EVER
NO. OF PATIENTS WITH RECORD IN LAST 6 MONTHS
Females with any Male Codes 5 0
Females with Male Operation Codes 3 0
Females with Male Disease Codes 2 0
FEMALE CODESIN MALE RECORDS
MALE CODESIN FEMALE RECORDSIMT DES
HOME
WRONG SEX AUDIT HOME
IM&T DES REFERRALS & LOCATIONS & SUMMARIES AUDIT
REFERRALS LOCATIONS SUMMARIESIMT DESHOME
REFERRALS, LOCATION,SUMMARY HOME
Referrals
Locations
Summaries
IM&T DES REFERRALS & LOCATIONS & SUMMARIES AUDIT
REFERRALS TOTAL NUMBER RATE PER 1000 PATIENTS
Total No. of Patients with Referral Codes in Last 12 Months 1414 190.1
Total No. of Patients with Medical Referral Codes in Last 12 Months 418 56.2
Total No. of Patients with Surgical Referral Codes in Last 12 Months 679 91.3
Total No. of Patients with Private Referral Codes in Last 12 Months 0 0.0
Total No. of Patients with Referral to Other Agencies Codes in Last 12 Months 372 50.0
Total No. of Patients with Uncategorised Referral Codes in Last 12 Months 128 17.2
Total No. of Medical Referral Codes in Last 12 Months 463 62.2
Total No. of Surgical Referral Codes in Last 12 Months 868 116.7
Total No. of Private Referral Codes in Last 12 Months 0 0.0
Total No. of Referral to Other Agencies Codes in Last 12 Months 549 73.8
Total No. of Uncategorised Referral Codes in Last 12 Months 128 17.2
REFERRALS LOCATIONS SUMMARIESIMT DESHOME
REFERRALS, LOCATION,SUMMARY HOME
IM&T DES REFERRALS & LOCATIONS & SUMMARIES AUDIT
LOCATIONS (From Clinical Supplier System Reports) TOTAL NUMBER RATE PER 1000 PATIENTS
Total No. of Surgery Encounters in Last 28 Days 1720 340.6
Total No. of Telephone Encounters in Last 28 Days 62 12.3
Total No. of Home Visits in Last 28 Days 32 6.3
REFERRALS LOCATIONS SUMMARIESIMT DESHOME
REFERRALS, LOCATION,SUMMARY HOME
IM&T DES REFERRALS & LOCATIONS & SUMMARIES AUDIT
SUMMARY ONCE PER DIAGNOSIS(From Clinical Supplier System Reports)
NO OF PATIENTSWITH RECORDS
NO OF PATIENTS WITH A RECORD WITH
SUMMARY FLAG
PERCENT OF PATIENTS WITH SUMMARY FLAG
Summaries for Cholecystectomies 0 0 0.0%
Summaries for Chronic Bronchitis 2 2 100.0%
Summaries for Hypothyroidism 0 0 0.0%
Summaries for Colectomies 0 0 0.0%
Summaries for Rheumatoid Arthritis 1 0 0.0%
Summaries for Breast Cancer 0 0 0.0%
Summaries for Essential Hypertension 6 5 83.3%
Summaries for Ulcerative Colitis 0 0 0.0%
Summaries for Multiple Sclerosis 0 0 0.0%
Summaries for Parkinsons Disease 0 0 0.0%
Summaries for Dementia 2 0 0.0%
↓ ↓ ↓ ↓
Summaries for Glaucoma 0 0 0.0%
REFERRALS LOCATIONS SUMMARIESIMT DESHOME
REFERRALS, LOCATION,SUMMARY HOME
TOP LEVEL CODES AUDIT
TOP LEVEL CODES TOTAL NO. OF PATIENTSWITH TOP LEVEL CODE
RATE PER1000 PATIENTS
Total No. of Patients with Top Level Codes 26 3.5
Total No. of Patients with [A….] Codes 0 0.0
Total No. of Patients with [B…. Or XE1vN] Codes 0 0.0
Total No. of Patients with [C…. Or Xa9AI] Codes 12 2.0
Total No. of Patients with [D…. Or X20Bj] Codes 0 0.0
Total No. of Patients with [E….] Codes 0 0.0
Total No. of Patients with [F…. Or X000E] Codes 4 1.0
Total No. of Patients with [G…. Or XE0UX] Codes 0 0.0
Total No. of Patients with [H….] Codes 2 0.0
Total No. of Patients with [J….] Codes 0 0.0
Total No. of Patients with [K…. Or X30Hb] Codes 0 0.0
↓ ↓ ↓
Total No. of Patients with [Z….] Codes 0 0.0
DRUGS TO DISEASEAUDITS
ALLERGYAUDIT
CHOLECYSTECTOMYAUDIT
HYSTERECTOMYAUDIT
WRONG SEXAUDIT
REFERRALS, LOCATION,SUMMARY AUDIT
TOP LEVEL CODESAUDIT
CHOOSE ANOTHERLIBRARY
IM&T DES HOME
PNEUMOCOCCALPNEUMO SUMMARY
SHEET – PART 1PNEUMO SUMMARY
SHEET – PART 2CHOOSE
ANOTHERLIBRARY
PNEUMOCOCCALHOME
The aim of this query set is to support the Chief Medical Officer Immunisation Programme for older people and risk groups. The Pneumococcal (PPV) Vaccine Uptake CHART Library has been designed to provide the details of vaccinations given to people 65 and over and ‘At-risk groups' as per the Chief Medical Officer’s (CMO) Letter of 31st March 2005.
PNEUMOCOCCAL VACCINATION
PNEUMOCOCCAL VACCINATION UPTAKE SURVEY 2009Patient age on 31st March 2009 as defined using the Dates of Birth (DOB) below
Number of patients registered in the day
data is extracted
Number of registered patients that have
received the pneumococcal vaccine between 1st April 2008 and 31st March 2009
Number of patients that have received the pneumococcal vaccine at any time (including
the last year) on or before 31st March
% Uptake (vaccinated in the last year)
% Uptake (vaccinated anytime before 31st
March 09)
Aged 65 and over 575 21 329 3.65% 57.22%
Aged 2 to 15 750 0 1 0.00% 0.13%
Aged 16 to 64 3925 4 107 0.10% 2.73%
Aged 65 33 5 10 15.15% 30.30%
66 to 74 268 13 161 4.85% 60.07%
75 to 79 108 3 74 2.78% 68.52%
80+ 166 0 84 0.00% 50.60%
No. of males aged 65 and over
269 11 145 4.09% 53.90%
No. of females aged 65 and over
306 10 184 3.27% 60.13%
PNEUMO SUMMARYSHEET – PART 1
PNEUMO SUMMARYSHEET – PART 2
CHOOSE ANOTHERLIBRARY
PNEUMOCOCCALHOME
PNEUMOCOCCAL VACCINATION
PNEUMOCOCCAL VACCINATION UPTAKE SURVEY 2009Patient age on 31st March 2009 as defined using the Dates of Birth (DOB) below
Number of patients registered in the day
data is extracted
Number of registered patients that have
received the pneumococcal vaccine between 1st April 2008 and 31st March 2009
Number of patients that have received the pneumococcal vaccine at any time (including
the last year) on or before 31st March
% Uptake (vaccinated in the last year)
% Uptake (vaccinated anytime before 31st
March 09)
Summary of Patients in one or more Risk Group(s)
Aged 2 to 15 750 0 1 0.00% 0.13%
Aged 16 to 64 3925 4 107 0.10% 2.73%
Aged 65 33 5 10 15.15% 30.30%
Patients with Asplenia or Dysfuction of the Spleen (re-immunisation recommended every 5 years)
Aged 2 to 15 750 0 1 0.00% 0.13%
Aged 16 to 64 3925 4 107 0.10% 2.73%
Aged 65 33 5 10 15.15% 30.30%
Same information as above is provided for Chronic Respiratory Disease, Chronic Heart Disease, Chronic Kidney Disease, Chronic Liver Disease, Diabetes, Immunosuppression, HIV Infection, Bone Marrow Transplant, Cochlear Implants, Cerebrospinal Fluid Leaks, Cancer on or after 1/4/ 2008, Asthma on continuous or repeated steroids.
PNEUMO SUMMARYSHEET – PART 1
PNEUMO SUMMARYSHEET – PART 2
CHOOSE ANOTHERLIBRARY
PNEUMOCOCCALHOME
TOTAL PRACTICE POPULATION 10620
Population
Latest MI in last 12 months
Latest MI over 12 months ago TOTAL
No. of Patients who have had an MI 7 130 137Percent of Practice Population 0.07% 1.22% 1.29%
NO. OF PATIENTS PERCENTAGE OF PATIENTS
Advice and Procedures Post MI
Latest MI in last 12 months
Latest MI over 12 months ago TOTAL
Latest MI in last 12 months
Latest MI over 12 months ago TOTAL
No. of patients offered exercise advice since last MI 1 37 38 14.3% 28.5% 28%No. of patients whose latest smoking status shows them as smokers 2 11 13 28.6% 8.5% 8%No. of patients given advice to quit smoking since MI 1 53 54 14.3% 40.8% 41%No. of patients referred to cessation service since MI 0 0 0 0.0% 0.0% 0%No. of patients offered dietary advice since last MI 1 33 34 14.3% 25.4% 25%No. of patients offered Cardiac Rehabilitation since last MI 1 1 2 14.3% 0.8% 1%No. of patients recorded as having Bypass Surgery since last MI 1 5 6 14.3% 3.8% 4%No. of patients recorded as having Angioplasty since last MI 1 8 9 14.3% 6.2% 6%No. of patients recorded as having a Stent inserted since last MI 3 16 19 42.9% 12.3% 12%
Medication Post MI ACEI AspirinBETA BLOCKER STATIN
No. of patients with issue for each drug in last three months 98 94 89 106No. of patients with contra-indication code for each drug 1 6 12 2Percent on each drug out of all those post MI minus those with contra-indication 72% 72% 71% 79%
Audit of NICE Guidance on the secondary prevention of MI and Review of Acute Coronary Syndromes.
Overall Treatment
4 of the above drugs
3 of the above drugs
2 of the above drugs
1 of the above drugs
0 of the above drugs TOTAL
No. of Post MI patients on or with contra-indication to the combination of drugs 47 53 26 9 2 137
Heart Failure Total
Licensed Aldosterone Antagonist issued in last 3 mths
Potassium checked in Last 3 Months
Patients who have had an MI and Left Ventricular Systolic Dysfunction 6 1 2 Go to Dashboard view
Diagnostic Categories v Current Clopidogrel TreatmentTreatment Advised
Clopidgorel issued L3M
Clopidogrel not issued
STEMI in last 1 month Yes 0 0NSTEMI in last 12 months Yes 2 0STENT in last 12 months Yes 3 4Unspecified MI in last 12 months (Does not distinguish STEMI from NSTEMI) Ambiguous 1 0STEMI more than 1 month ago No 2 5NSTEMI more than 12 months ago No 0 5STENT more than 12 months ago No 3 25Unspecified MI more than 12 months ago No 5 98ACS Only No 3 10
Recording of Latest Myocardial Infarctions by Category No. in L12M No. > L12MPositional i.e. Antero-Lateral or Posterior 1 8Q Wave 0 0Non Q Wave 0 1Sub-Endocardial 0 2STEMI 1 3NSTEMI 3 4Micro-Infarction 0 0MI Aborted 0 0Unspecified 2 112TOTAL 7 130
Go to Dashboard viewLatest Acute Coronary Syndrome by Category No. in L12M No. > L12MAcute MI 3 109STEMI 1 3NSTEMI 3 4MI Aborted 0 0Unstable Angina 1 10Angina Other 0 0Preinfarction Syndrome 0 0Microinfarction 0 0ACS 1 2Other 4 20TOTAL 13 148
MIACS SUMMARY SHEET
CHARTS DATA SHEETMAIN MENU
SUMMARY SHEET
CHART GRAPH EXAMPLES 1 – 2 – 3
CHARTS DATA SHEETMAIN MENU
SUMMARY SHEET
CHART GRAPH EXAMPLES 1 – 2 – 3
CHARTS DATA SHEETMAIN MENU
SUMMARY SHEET
CHART GRAPH EXAMPLES 1 – 2 – 3
CHARTS DATA SHEETMAIN MENU
SUMMARY SHEET
MIACS DATASHEET CLICK HERE FOR MORE OF DATASHEET
CHARTS DATA SHEETMAIN MENU
SUMMARY SHEET
Note – CHART can bring back either anonymised references or patient names
MIACS DATASHEET CLICK HERE FOR MORE OF DATASHEETCLICK HERE FOR MORE OF DATASHEET
CHARTS DATA SHEETMAIN MENU
SUMMARY SHEET
Note – CHART can bring back either anonymised references or patient names
MIACS DATASHEETCLICK HERE FOR MORE OF DATASHEET CLICK HERE FOR MORE OF DATASHEET
CHARTS DATA SHEETMAIN MENU
SUMMARY SHEET
Note – CHART can bring back either anonymised references or patient names
MIACS DATASHEETCLICK HERE FOR MORE OF DATASHEET
CHARTS DATA SHEETMAIN MENU
SUMMARY SHEET
Note – CHART can bring back either anonymised references or patient names
CHART ONLINE is a database maintained by PRIMIS+. For specific libraries practices can upload data from CHART to this database. These libraries are currently:
The practices can then, via the internet, log into the CHART Online software and look at useful graphs which compare their results with those of their fellow practices.
Results from other practices are anonymised.
You can see some of these graphs by clicking the above buttons.
CHART ONLINEEXAMPLE CHART 1 EXAMPLE CHART 2 EXAMPLE CHART 3
EXAMPLE CHART 4MAIN MENU
CHART ONLINE HOME
EXAMPLE CHART 1 EXAMPLE CHART 2 EXAMPLE CHART 3
EXAMPLE CHART 4MAIN MENU
CHART ONLINE HOME
CHART ONLINE
Chart showing patients with prescription of Tamoxifen and percentage with a diagnosis of Breast Cancer
CHART ONLINE
Chart showing patients with pacemakers and whether this shows on GP’s summary screen when they starts consultation
EXAMPLE CHART 1 EXAMPLE CHART 2 EXAMPLE CHART 3
EXAMPLE CHART 4MAIN MENU
CHART ONLINE HOME
CHART ONLINE
Chart showing hysterectomy coding, including patients who have had hysterectomies coded more than once.
